Gene therapy for retinal and choroidal diseases

Bibliography

• LI L, TURNER JE: Inherited retinal dystrophy in the RCS rat: prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp. Eye Res. (1988) 47:911–918.
   PubMed Web of Science ®Google Scholar
• BUDENZ DL, BENNETT J, ALONSO L, MAGUIRE A: In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. (1995) 36:2211–2215.
   PubMed Web of Science ®Google Scholar
• MORI K, GEHLBACH P ANDO A et al: Intraocular adenoviral vector-mediated gene transfer is increased in proliferative retinopathies. Invest. Ophthalmol. Vis. Sci. (2002) 93:1610–1615.
   Google Scholar
• RAKOCZY PE, LAI CM, SHEN WY, DAW N, CONSTABLE IJ: Recombinant adenovirus-mediated gene delivery into the rat retinal pigment epithelium in vivo. Aust. NZ J. Ophthalmol. (1998) 26:S56–S58.
   PubMedGoogle Scholar
• ANGLADE E, CSAKY KG: Recombinant adenovirus-mediated gene transfer into the adult rat retina. Cup: Eye Res. (1998) 17:316–321.
   PubMed Web of Science ®Google Scholar
• CAYOUETTE M, GRAVEL C: Adenovirus-mediated gene transfer to retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. (1996) 37:2022–2028.
   PubMed Web of Science ®Google Scholar
• BENNETT J, PAKOLA S, ZENG Y, MAGUIRE A: Humoral response after administration of El-deleted adenoviruses: immune privilege of the subretinal space. Hum,. Gene Ther. (1996) 7:1763–1769.
   PubMed Web of Science ®Google Scholar
• REICHEL MB, ALT RR, THRASHER AJ,HUNT DM, BHATTACHARYA SS, BAKER D: Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther. (1998) 5:1038–1046.
   PubMed Web of Science ®Google Scholar
• SHEN WY, LAI MC, BEILBY J et al.: Combined, effect of cyclosporine and sirolimus on improving the longevity of recombinant adenovirus-mediated transgene expression in the retina. Arch. Ophthalmol. (2001) 119:1033–1043.
   PubMed Web of Science ®Google Scholar
• KUMAR-SINGH R, FARBER DB: Encapsidated, adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration. Hum. MM. Genet. (1998) 7:1893–1900.
   PubMed Web of Science ®Google Scholar
• •Demonstrates potential for gutless Ad vectors, for ocular gene replacement therapy.
   Google Scholar
• FLANNERY JG, ZOLOTUKHIN S, VAQUERO, MI, LAVAIL MM, MUZYCZKA N, HAUSWIRTH WW: Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl. Acad. Sci. USA (1997) 94:6916–6921.
   PubMed Web of Science ®Google Scholar
• •AAV vectors produce little or no inflammatory response, efficiently transduce retinal ganglion cells, RPE cells, and photoreceptors, and mediate long-term transgene expression. These characteristics indicate that AAV vectors have tremendous potential for ocular gene therapy.
   Google Scholar
• BENNETT J, DUAN D, ENGELHARDT JF, MAGUIRE AM: Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest. Ophthalmol Vis. Sci. (1997) 38:2857–2863.
   PubMed Web of Science ®Google Scholar
• ALT RR, REICHEL MB, DE ALWIS M et al.: Adeno-associated virus gene transfer to mouse retina. Hum. Gene Ther. (1998) 9:81–86.
   Google Scholar
• BENNETT J, MAGUIRE AM, CIDECIYAN AV et al.: Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl. Acad. Sci. USA (1999) 96:9920–9925.
   PubMed Web of Science ®Google Scholar
• GUY J, QI X, MUZYCZKA N, HAUSWIRTH, WW: Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch. Ophthalmol (1999) 117:929–937.
   PubMed Web of Science ®Google Scholar
• •AAV vectors produce little or no inflammatory response, efficiently transduce retinal ganglion cells, RPE cells, and photoreceptors, and mediate long-term transgene expression. These characteristics indicate that AAV vectors have tremendous potential for ocular gene therapy.
   Google Scholar
• MORI K, GEHLBACH P, YAMAMOTO S et aL: AAV-mediated gene transfer of pigment epithelium-derived factorinhibits choroidal neovascularization. Invest. Ophthalmol Vis. Sri. (2002). In press.
   Google Scholar
• •AAV vectors produce little or no inflammatory response, efficiently transduce retinal ganglion cells, RPE cells, and photoreceptors, and mediate long-term transgene expression. These characteristics indicate that AAV vectors have tremendous potential for ocular gene therapy.
   Google Scholar
• POZNANSKY M, LEVER A, BERGERON L,, HASELTINE W, SODROSKI J: Gene transfer into human lymphocytes by a defective, human immunodeficiency virus Type 1 vector.j Virol (1991) 65:532–536.
   PubMed Web of Science ®Google Scholar
• NALDINI L, BLOMER U, GAGE FH, TRONO D, VERMA IM: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA (1996) 93:11382–11388.
   PubMed Web of Science ®Google Scholar
• NALDINI S, BLOMER U, GALLAY P et al.: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Sdence (1996) 272:263–267.
   Google Scholar
• BLOMER U, NALDINI L, KAFRI T, TRONO D, VERMA IM, GAGE FH: Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. Virol (1997) 71:6641–6649.
   Web of Science ®Google Scholar
• KAFRI T, BLOMER U, PETERSON D, GAGE FH, VERMA IM: Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. (1997) 17:314–317.
   PubMed Web of Science ®Google Scholar
• ZUFFEREY R, NAGY D, MANDEL RJ, NALDINI L, TRONO D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotech. (1997) 15:871–875.
   PubMed Web of Science ®Google Scholar
• ZUFFEREY R, DULL T, MANDEL RJ et al.: Self-activating lentivirus vectors for safe and efficient in vivo gene delivery. J. Viro/. (1998) 72:9873–9880.
   PubMed Web of Science ®Google Scholar
• GALLICHAN WS, KAFRI T, KRAHL T, VERMA IM, SARVETNICK N: Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum. Gene Ther. (1998) 9:2717–2726.
   PubMed Web of Science ®Google Scholar
• WU X, WAKEFIELD JK, LIU H et al.: Development of a novel trans-lentiviral vector that affords predictable safety. Ma Ther. (2000) 2:47–55.
   PubMed Web of Science ®Google Scholar
• BUCHSCHACHER GL JR, WONG-STAAL F: Development of lentiviral vectors for gene therapy for human disease. Blood (2000) 95:2499–2504.
   PubMed Web of Science ®Google Scholar
• VIGNA E, NALDINI L: Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. Gene Med. (2000) 2:308–316.
   Google Scholar
• TRONO D: Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene The]: (2000) 7:20–23.
   PubMed Web of Science ®Google Scholar
• MIYOSHI H, TAKAHASHI M, GAGE FH, VERMA IM: Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA (1997) 94:10319–10323.
   PubMed Web of Science ®Google Scholar
• •Lentiviral vectors evoke little or no immune response and mediate efficient long-term transduction in the retina indicating that they, like AAV vectors, have great potential for ocular gene therapy.
   Google Scholar
• TAKAHASHI K, LUO T, SAISHIN Yet al.: Sustained transduction of ocular cells with a bovine immunodeficiency viral vector. (2002). Hum. Gene Ther. (2002) 13. In press.
   Google Scholar
• JOHNSON PA, MIYANOHARA A, LEVINE F, CAHILL T, FRIEDMANN T: Cytotoxicity of replication-defective mutant of Herpes simplex virusType 1. " Virol (1992) 66:2952–2965.
   PubMed Web of Science ®Google Scholar
• FRAEFEL C, SONGS, LIM F et al: Helper virus-free transfer of Herpes simplex virus Type 1 plasmid vectors into neural cells. Virnl. (1996) 70:7190–7197.
   PubMed Web of Science ®Google Scholar
• FINK DJ, DELUCA NA, GOINS WE GLORIOSO JC: Gene transfer to neurons using herpes simplex virus-based vectors. Ann. Rev Neurosci. (1996) 19:265–287.
   PubMed Web of Science ®Google Scholar
• WOOD MJ, BYRNES AP, PFAFF DW, RABKIN SD, CHARLTON HM: Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene The]: (1994) 1:283–291.
   PubMed Web of Science ®Google Scholar
• SPENCER B, AGARWALA S, MISKULIN M,, SMITH M, BRANDT CR: Herpes simplex virus-mediated gene delivery to the rodent visual system. Invest. Ophthalmol Vis. Sci. (2000) 41:1392–1401.
   PubMed Web of Science ®Google Scholar
• SAKAMOTO T, KIMURA H, SCURIC Z et al.: Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Ophthalmology (1995) 102:1417–1424.
   PubMed Web of Science ®Google Scholar
• DRYJA TP, BERSON EL: Retinitis pigmentosa and allied diseases. Implications of genetic heterogeneity. Invest. Ophthalmol Vis. Sci. (1995) 36:1197–1200.
   PubMed Web of Science ®Google Scholar
• RATTNER A, SUN H, NATHANS J: Molecular genetics of human retinal disease. Ann. Rev Genet. (1999) 33:89–131.
   PubMed Web of Science ®Google Scholar
• MCLAUGHLIN ME, SANDBERG MA, BERSON EL, DRYJA TP: Recessive mutations in the gene encoding the beta subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat. Genet. (1993) 4:130–134.
   PubMed Web of Science ®Google Scholar
• PITTLER SJ, BAEHR W: Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc. Natl. Acad. Sci. USA (1991) 88:8322–8326.
   PubMed Web of Science ®Google Scholar
• SUBER ML, PITTLER SJ, QIN N et al.: Irish setter dogs affected with cone/rod dysplasia, contain a nonsense mutation in the rod cGMP phosphodiesterase beta-subunit gene. Proc. Natl. Acad. Sci. USA (1993) 90:3968–3972.
   PubMed Web of Science ®Google Scholar
• BENNETT J, TANABE T, SUN D et al.: Photoreceptor, cell rescue in retinal degeneration, (rd) mice by in vivo gene therapy. Nat. Med. (1996) 2:649–654.
   PubMed Web of Science ®Google Scholar
• •One of the first studies to provide proof of principle for ocular gene replacement therapy.
   Google Scholar
• TAKAHASHI M, MIYOSHI H, VERMA IM, GAGE FH: Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. Virol (1999) 73:7812–7816.
   Web of Science ®Google Scholar
• JOMARY C, VINCENT KA, GRIST J, NEAL MJ, JONES SE: Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Ther (1997) 4:683–690.
   PubMed Web of Science ®Google Scholar
• CONNELL GJ, MOLDAY RS: Molecularcloning, primary structure, and orientation of the vertebrate photoreceptor cell protein peripherin in the rod outer segment disk membrane. Biochemistry (1990) 29:4691–4698.
   PubMed Web of Science ®Google Scholar
• TRAVIS GH, BRENNAN MB, DANIELSON PE, KOZAK CA, SUTCLIFFE JG: Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature (1989) 338:70–73.
   PubMed Web of Science ®Google Scholar
• CONNELL G, BASCOM R, MOLDAY L, REID D, MCINNES RR, MOLDAY RS: Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse. Proc. Nati Acad. Sci. USA (1991) 88:723–726.
   PubMed Web of Science ®Google Scholar
• ALT RR, SARRA GM, STEPHENS C et al: Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat. Genet. (2000) 25:306–310.
   PubMed Web of Science ®Google Scholar
• SARRA GM, STEPHENS C, DE ALWIS M et al.: Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum. Ma Genet. (2001) 10:2353–2361.
   Google Scholar
• GAL A, LI Y, THOMPSON DA et al.: Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat. Genet. (2000) 26:270–271.
   PubMed Web of Science ®Google Scholar
• D'CRUZ PM, YASUMURA D, WEIR J et, al.: Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum. MM. Genet. (2000) 9:645–651.
   Google Scholar
• VOLLRATH D, FENG W, DUNCAN JL et al.: Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc. Nati Acad. Sci. USA (2001) 98:12584–12589.
   PubMed Web of Science ®Google Scholar
• REDMOND TM, YU S, LEE E et al.: RPE65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet. (1998) 20:344–351.
   PubMed Web of Science ®Google Scholar
• MARLHENS F, BAREIL C, GRIFFOIN J- M, et al.: Mutations in RPE65 cause Leber's congenital amaurosis. Nat. Genet. (1997) 17:139–141.
   Google Scholar
• GU S-M, THOMPSON DA, SRIKUMARI CR et al.: Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat. Genet. (1997) 17:139–141.
   PubMedGoogle Scholar
• AGUIRRE GD, BALDWIN V, PEARCE-KELLING S et al.: Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect. Mo/. Vis. (1998) 4:23.
   PubMedGoogle Scholar
• ACLAND GM, AGUIRRE GD, RAY J et al.: Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet. (2001) 28:92–95.
   PubMed Web of Science ®Google Scholar
• ••First demonstration of return of visualfunction after ocular gene replacement in a large animal. This study provides strong incentive for a clinical trial to investigate gene transfer for treatment of patients with Leber's congenital arnaurosis due to mutations in RPE-65.
   Google Scholar
• TAKKI K, SIMELL 0: Gyrate atrophy ofthe choroid and retina with hyperornithinemia HOGA. Birth Defects (1976) 12:373–384.
   PubMedGoogle Scholar
• O'DONNELL JJ, SANDMAN RP, MARTIN SR: Gyrate atrophy of the retina: inborn error of L-ornithine: 2-oxoacid aminotransferase. Sdence (1978) 90:200–201.
   Google Scholar
• LIT, DAVIDSON BL: Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA (1995) 92:7700–7704.
   PubMed Web of Science ®Google Scholar
• DRENSER KA, TIMMERS AM, HAUSWIRTH WW, LEWIN AS: Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest. Ophthalmol Vis. Sci. (1998) 39:681–689.
   PubMed Web of Science ®Google Scholar
• LEWIN AS, DRENSER KA, HAUSWIRTH, WW et al.: Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat. Med. (1998) 4:967–971.
   PubMed Web of Science ®Google Scholar
• ••Proof of concept for ribozyme gene therapyfor dominantly inherited retinal degenerations.
   Google Scholar
• LAVAIL MM, YASUMURA D, MATTHES MT et al.: Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy. Proc. Natl. Acad. Sci. USA (2000) 97:11488–11493.
   PubMed Web of Science ®Google Scholar
• CAYOUETTE M, GRAVEL C: Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum. Gene Ther. (1997) 8:423–430.
   PubMed Web of Science ®Google Scholar
• CAYOUETTE M, BEHN D, SENDTNER M,, LACHAPELLE P, GRAVEL C: Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J. Neurosci. (1998) 18:9282–9293.
   PubMed Web of Science ®Google Scholar
• LIANG F-Q, ALEMAN TS, DEJNEKA NS et, al: Long-term protection of retinal structure but not function using rAAV.CNTF in animal models of retinitis pigmentosa. Mol. Ther. (2001) 4:461–472.
   Google Scholar
• •Provides evidence that precise control of transgene expression may be needed for gene replacement of defective photoreceptor genes that cause retinal degeneration.
   Google Scholar
• LAUD, MCGEE H, ZHOU S et al: Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest. Ophthalmol Vis. Sci. (2000) 41:3622–3633.
   PubMed Web of Science ®Google Scholar
• YAMADA H, YAMADA E, ANDO A et al.:Fibroblast growth factor-2 decreases hypercoda-induced photoreceptor cell death in mice. 1 Am. Pathol (2001) 159:1113–1120.
   Google Scholar
• AKIMOTO M, MIYATAKE S, KOGISHI J et al.: Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest. Oplithalmol Vis. Sci. (1999) 40:273–279.
   PubMed Web of Science ®Google Scholar
• NEUNER-JEHLE M, BERGHE LV, BONNEL S et al.: Ocular cell transfection with the human basic fibroblast growth factor gene delays photoreceptor cell degeneration in RCS rats. Hum. Gene Ther. (2000) 11:1875–1890.
   PubMed Web of Science ®Google Scholar
• MCGEE SANFTNER LH, ABEL H, HAUSWIRTH WW, FLANNERY JG: Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. MM. Tiler. (2001) 4:622–629.
   PubMed Web of Science ®Google Scholar
• •Demonstrates preservation of structure and function in an animal model of mutation-induced photoreceptor degeneration by gene transfer of GDNE
   Google Scholar
• KORSMEYER SJ, SHUTTER JR, YEIS DJ, MERRY DE, OLTVAI ZN: Bc1-2/13ax: a rheostat that regulates an antioxidant pathway and cell death. Semin. Cancer Bic] (1993) 4:327–332.
   PubMed Web of Science ®Google Scholar
• BENNETT J, ZENG Y, BAJWA R, KLATT S, LI Y, MAGUIRE AM: Adenovirus-mediated delivery of rhodopsin-promoted bc1-2 results in a delay in photoreceptor cell death in the rd/rd mouse. Gene Ther. (1998) 5:1156–1164.
   PubMed Web of Science ®Google Scholar
• KLEIN R, KLEIN BEK, MOSS SE, DAVISMD, DEMETS DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalincl. (1984) 102:520–526.
   Google Scholar
• THE MACULAR PHOTOCOAGULATION, STUDY GROUP: Argon laser photocoagulation for neovascular maculopathy: five year results from randomized clinical trials. Arch. Ophthalincl. (1991) 109:1109–1114.
   PubMed Web of Science ®Google Scholar
• CAMPOCHIARO PA: Retinal and choroidal neovascularization. I Cell. Physic] (2000) 184:301–310.
   PubMed Web of Science ®Google Scholar
• SEO M-S, KWAK N, OZAKI H et al: Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am. J. Pathcl (1999) 154:1743–1753.
   PubMed Web of Science ®Google Scholar
• OZAKI H, SEO M-S, OZAKI K et al.: Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am. J. Pathcl (2000) 156:697–707.
   PubMed Web of Science ®Google Scholar
• KWAK N, OKAMOTO N, WOOD JM, CAMPOCHIARO PA: VEGF is major stimulator in model of choroidal neovascularization. Invest. Ophthalincl Vis. Sci. (2000) 41:3158–3164.
   PubMed Web of Science ®Google Scholar
• O'REILLY MS, HOLMGREN L, SHING Y et al.: Angiostatin: a novel angiogenesis inhibitor, that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 79:315–328.
   Google Scholar
• O'REILLY MS, BOEHM T, SHING Y et al.: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 88:277–285.
   Google Scholar
• O'REILLY MS, PIRIE-SHEHERD S, LANE WS, FOLKMAN J: Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science (1999) 285:1926–1928.
   PubMed Web of Science ®Google Scholar
• MAIONE TE, GRAY GS, PETRO J et al: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science (1990) 247:77–79.
   PubMed Web of Science ®Google Scholar
• GOOD DJ, POLVERINI PJ, RASTINEJAD, F et al: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA (1990) 87:6624–6628.
   PubMed Web of Science ®Google Scholar
• DAWSON DW, VOLPERT OV, GILLIS P et al.: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Sdence (1999) 285:245–248.
   Google Scholar
• •First evidence that PDEF has antiangiogenic activity.
   Google Scholar
• MORI K, ANDO A, GEHLBACH P et al: Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am. J. Athol (2001) 159:313–320.
   PubMed Web of Science ®Google Scholar
• TOMBRAN-TINK J, CHADER GG, JOHNSON SV: PEDF: a pigment epithelium derived factor with potent neuronal differentiating activity. Exp. Eye Res. (1991) 53:411–414.
   PubMed Web of Science ®Google Scholar
• STEELE FR, CHADER GJ, JOHNSON LV, TOMBRAN-TINK J: Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. USA (1993) 90:1526–1530.
   PubMed Web of Science ®Google Scholar
• MORI K, DUH E, GEHLBACH P et al.: Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. Cell. Physic] (2001) 188:253–263.
   PubMed Web of Science ®Google Scholar
• MORI K, GEHLBACH P, ANDO A et al.: Regression of ocular neovascularization by increased expression of pigment epithelium-derived factor. Invest. Ophthalmcl. Vis. Sci. (2001) 188:253–263.
   Google Scholar
• •Provides proof of concept for ocular a,ntiangiogenic gene therapy and establishes PDEF as an extremely promising therapeutic agent.
   Google Scholar
• LAI C-C, WU W-C, CHEN S-L et al: Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. Invest. Ophthalmcl. Vis. Sci. (2001) 42:2401–2407.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI T, NAKAMURA T, HAYASHI A et al.: Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelial cells. Am. J. Ophthalmcl. (2000) 130:774–781.
   PubMed Web of Science ®Google Scholar
• HANGAI M, MOON YS, KITAYA Net al.: Systemically expressed soluble Tie2 inhibits intraocular neovascularization. Hum. Gene Ther. (2001) 12:1311–1321.
   Google Scholar
• HONDA M, SAKAMOTO T, ISHIBASHI T, INOMATA H, UENO H: Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration. Gene Ther. (2000) 7:978–985.
   PubMed Web of Science ®Google Scholar
• LAI C-M, BRANKOV M, ZAKNICH T et al.: Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum. Gene Ther. (2001) 12:1299–1310.
   PubMed Web of Science ®Google Scholar
• DEMETRIADES AM, GEHLBACH P, YAMAMOTO S et al.: Periocular injection of an adenoviral vector expressing the extracellular portion of vascular endothelial growth factor receptor-1 (Adsflt.10) inhibits choroidal neovascularization (CNV). Invest. Ophthalmcl. Vis. Sci (2002) 43. In press.
   Google Scholar
• GEHLBACH P, YAMAMOTO S, DEMETRIADES AM et al.: Periocular adenovirus-mediated delivery of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmcl. Vis. Sci. (2002) 43. In press.
   Google Scholar